| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |